Education
About Us
Working with TipRanks
Follow Us
BrightSpring Health Services, Inc. (BTSG)
:BTSG
RESEARCH TOOLSreports
Earnings Data
Report Date
Oct 31, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.28Last Year’s EPS
0.11Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance, with significant revenue and EBITDA growth across segments, especially in Pharmacy Solutions and Provider Services. The company successfully launched new therapies in Specialty Pharmacy and reported high patient satisfaction. However, challenges such as flat EBITDA margins, home health rate concerns, and a customer bankruptcy were noted. Overall, the positive aspects outweighed the negative, indicating a strong outlook.Company Guidance -
Q3 2025
Strong Revenue and EBITDA Growth
BrightSpring reported a 29% year-over-year increase in total company revenue, reaching $3.1 billion. Adjusted EBITDA also grew by 29% to $143 million in the second quarter of 2025.
Pharmacy Solutions Segment Success
Pharmacy Solutions revenue grew 32% year-over-year to $2.8 billion, driven by a 39% increase in Infusion and Specialty revenue and an 11% increase in Home & Community Pharmacy revenue.
Provider Services Expansion
Provider Services revenue grew 11% year-over-year to $358 million, with home healthcare revenue up 17%, rehab revenue up 9%, and personal care revenue up 4%.
Market Leadership in Specialty Pharmacy
Specialty scripts grew 38% in the second quarter, with 5 LDD launches. The LDD portfolio expanded to 133 therapies, with plans for 16 to 18 additional launches over the next 12 to 18 months.
High Patient Satisfaction and Performance Metrics
BrightSpring reported high patient satisfaction scores across various segments, including a 99% satisfaction score in rehab and a 98% timely initiation of care in home health.
Updated 2025 Guidance
The company increased its total revenue guidance to $12.2 billion to $12.6 billion and adjusted EBITDA guidance to $590 million to $605 million for the full year 2025.
BrightSpring Health Services, Inc. (BTSG) Earnings, Revenues Date & History
BTSG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BTSG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 01, 2025 | $20.65 | $19.64 | -4.89% |
May 02, 2025 | $17.90 | $20.87 | +16.59% |
Mar 06, 2025 | $18.39 | $17.23 | -6.31% |
Nov 01, 2024 | $14.97 | $17.25 | +15.23% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BrightSpring Health Services, Inc. (BTSG) report earnings?
BrightSpring Health Services, Inc. (BTSG) is schdueled to report earning on Oct 31, 2025, Before Open (Confirmed).
What is BrightSpring Health Services, Inc. (BTSG) earnings time?
BrightSpring Health Services, Inc. (BTSG) earnings time is at Oct 31, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BTSG EPS forecast?
BTSG EPS forecast for the fiscal quarter 2025 (Q3) is 0.28.